T. Kato et al. / Carbohydrate Research 448 (2017) 10e17
15
128.72e127.72 (10C, arom.); 98.69 (C1); 80.35 (C3); 77.86 (C4);
75.52, 75.04 (2C, -CH2- x2); 71.19 (C5); 63.67 (C2); 61.16 (t, JC-
4.1.12. Methyl 2-azido-2-deoxy-3,4-di-O-benzy-6-O-p-
toluenesulfonyl-6-(S)-deuterio- -glucopyranoside (16)
A solution of 15 (55.0 mg, 0.137 mmol) in pyridine (0.5 mL) and
a-D
¼ 22.4 Hz, C6); 55.24 (-OCH3). ESI-HRMS: m/z calcd for
a
D
C
½
21H24DN3O5Na [M
ꢀ
þ
Na]þ 423.1755, found 423.1761.15
b:
p-toluenesulfonyl chloride (39.2 mg, 0.206 mmol) was stirred at
ambient temperature for 2 h, with monitoring by TLC (hexane:ethyl
acetate 2:1, Rf ¼ 0.40). The reaction mixture was diluted with ethyl
acetate and washed with 1 N hydrochloric acid. The aqueous layer
was extracted with ethyl acetate and the combined extracts were
washed with saturated aqueous sodium bicarbonate and brine,
dried, concentrated and purified by silica gel column chromatog-
raphy (hexane:ethyl acetate 4:1 to 2:1) to give the tosylate 16 as a
a 2D3
¼ ꢁ26.9 (c ¼ 0.3). 1H NMR (600 MHz, CDCl3):
¼ 7.39e7.27 (m,
d
10H, arom.); 4.89 (d, JCHa-CHb ¼ 10.6 Hz, 1H, -CH2aPh); 4.85; (d, JCHa’-
¼ 11.0 Hz, 1H, -CH2a’Ph); 4.83 (d, JCHb-CHa ¼ 10.6 Hz, 1H,
CHb’
-CHbPh); 4.66 (d, JCHb’-CHa’ ¼ 11.0 Hz, 1H, -CH2b’Ph); 4.21 (d, J1-
¼ 8.1 Hz, 1H, H1); 3.71 (d, J6-5 ¼ 4.4 Hz, 1H, H6); 3.59 (t, J4-3 ¼ J4-
2
¼ 9.4 Hz, 1H, H4); 3.57 (s, 3H, -OCH3); 3.46 (t, J3-2 ¼ J3-4 ¼ 9.5 Hz,
5
1H, H3); 3.37 (dd, J2-1 ¼ 8.1 Hz, J2-3 ¼ 9.7 Hz, 1H, H2); 3.33 (dd, J5-
¼ 9.6 Hz, J5-6 ¼ 4.4 Hz, 1H, H5). 13C NMR (150 MHz, CDCl3):
colorless oil (58.4 mg, 0.105 mmol, 77%). ½a D23
ꢀ
¼ þ68.1 (c ¼ 0.5). 1H
4
d
¼ 137.78, 137.69 (2C, arom.); 128.60e127.87 (10C, arom.); 103.01
NMR (600 MHz, CDCl3):
d
¼ 7.78 (d, J ¼ 8.4 Hz, 2H, arom); 7.38e7.27
(C1); 82.93 (C3); 77.35 (C4); 75.57(-CH2PH); 75.17 (C5); 75.12
(-CH2PH); 66.32 (C2); 61.33 (t, JC-D ¼ 23.6 Hz, C6); 57.31 (-OCH3).
ESI-HRMS: m/z calcd for C21H24DN3O5Na [M þ Na]þ 423.1755,
found 423.1747.
(m, 10 H, arom); 7.18 (dd, J ¼ 2.2 Hz, 7.7 Hz, 2H, arom); 4.88 (d, JCH2a-
¼ 10.6 Hz, 1H, -CH2aPh); 4.82 (d, JCH2b-CH2a ¼ 10.6 Hz, 1H,
CH2b
-CH2bPh); 4.81 (d, JCH2a’-CH2b’ ¼ 10.6 Hz, 1H, -CH2a’Ph); 4.47 (d, J1-
¼ 3.7 Hz, 1H, H1); 4.47 (d, JCH2b’-CH2a’ ¼ 10.6 Hz, 1H, -CH2b’Ph); 4.21
2
(d, J6-5 ¼ 4.4 Hz, 1H, H6); 3.94 (dd, J3-2 ¼ 9.9 Hz, J3-4 ¼ 9.0 Hz, 1H,
H3); 3.80 (dd, J5-4 ¼ 10.1 Hz, J5-6 ¼ 4.4 Hz, 1H, H5); 3.51 (dd, J4-
4.1.10. Methyl 6-(S)-deuterio-a-D-glucosaminide monoacetate
¼ 9.1 Hz, J4-5 ¼ 10.1, 1H, H4); 3.36 (s, 3H, -OCH3); 3.34 (dd, J2-
3
(6S-2H-4)
¼ 3.7 Hz, J2-3 ¼ 10.1 Hz, 1H, H2); 2.41 (s, 3H, -SO2PhCH3). 13C NMR
1
To a solution of 15a (30 mg, 0.075 mmol) in 1,4-dioxane (1 mL)
(150 MHz, CDCl3)
d
¼ 144.97, 137.60, 137.42, 132.81 (4C, arom);
was added the same weight of 10% palladium hydroxide on acti-
vated charcoal. The reaction mixture was stirred 6 H under 1 atm of
hydrogen atmosphere. Water (0.1 mL) was then added and the
pressure adjusted to 3 atm of hydrogen. After stirring for 12 h the
catalyst was filtered off and washed with water until the washings
gave a negative ninhydrin test. The filtrate was concentrated and
dried under reduced pressure. The residue was dissolved in
methanol (0.5 mL) and slurried with silica gel. The methanol was
removed in vacuo and the powder applied to a silica gel column
that was eluted with chloroform:methanol:ammonium hydroxide
3:1:0.5, Rf ¼ 0.25. The concentrated fractions were taken up in the
minimum volume of 10% aqueous acetic acid and purified by
Sephadex C-25 column (eluent: water then 2% ammonium hy-
130.00e127.75 (14C, ar0om); 98.53 (C1); 80.30 (C3); 77.43 (C4);
75.48 (CH2); 75.02 (CH2 ); 68.90 (C5); 67.97 (t, JC-D ¼ 22.4 Hz, C6);
63.40 (C2); 55.40 (-OCH3); 21.64 (PhCH3). ESI-HRMS: m/z calcd for
C
28H30DN3O7SNa [M þ Na]þ 577.1843, found 577.1851.
4.1.13. Methyl 2,6-diazido-2,6-dideoxy-3,4-di-O-benzyl-6-(R)-
deuterio- -glucopyranoside (17)
a-D
A solution of 16 (85.0 mg, 0.153 mmol) in 9:1 N,N-dime-
thylformamide:water (1.2 mL) mixture was treated sodium azide
(119 mg, 1.84 mol) and heated to 85 ꢂC for 8 h with stirring, and
monitoring by TLC (hexane:ethyl acetate 3:1, Rf ¼ 0.45). On
completion the reaction mixture was diluted with ethyl acetate and
washed with water. The aqueous layer was extracted with ethyl
acetate and the combined organic layer was washed with brine,
dried, concentrated, and purified by column chromatography
(hexane:ethyl acetate 6:1 to 3:1) to give 17 as white foam (52.2 mg,
droxide). Glacial acetic (50
mL) acid was added to the product-
containing fractions, followed by drying under vacuum to give
the title compound 6S-2H-4 as colorless oil (10.4 mg, 0.041 mmol,
55%), whose non-deuteriated isotopomer was previously reported
0.123 mmol, 80%). ½a D23
ꢀ
¼ þ59.3 (c ¼ 0.5). 1H NMR (600 MHz,
as the free base [29]. ½a D23
ꢀ
¼ þ152.3 (c ¼ 0.1, water). 1H NMR
CDCl3):
d
¼ 7.42e7.22 (m, 10H, arom); 4.89 (d, JCH2a-CH2b ¼ 10.6 Hz,
(600 MHz, D2O):
d
¼ 4.85 (d, J1-2 ¼ 3.7 Hz, 1H, H1); 3.86 (t, J3-2 ¼ J3-
1H, -CH2aPh); 4.88 (d, JCH2a’-CH2b’ ¼ 11.0 Hz, 1H, -CH2a’Ph); 4.84 (d,
JCH2b-CH2a ¼ 10.6 Hz, 1H, -CH2bPh); 4.80 (d, J1-2 ¼ 3.4 Hz, 1H, H1);
4.59 (d, JCH2b’-CH2a’ ¼ 11.0 Hz, 1H, -CH2b’Ph); 3.97 (dd, J3-2 ¼ 10.3 Hz,
J3-4 ¼ 9.2 Hz, 1H, H3); 3.81 (dd, J5-4 ¼ 9.8 Hz, J5-6 ¼ 2.2 Hz, 1H, H5);
3.52 (t, J4-3 ¼ J4-5 ¼ 9.5, 1H, H4); 3.46 (d, J6-5 ¼ 2.2 Hz, 1H, H6); 3.44
¼ 9.7 Hz, 1H, H3); 3.60 (d, J6-5 ¼ 5.1 Hz, 1H, H6); 3.53 (dd, J5-
¼ 9.8 Hz, J5-6 ¼ 5.1 Hz, 1H, H5); 3.31 (t, J4-3 ¼ J4-5 ¼ 9.7 Hz, 1H,
4
4
H4); 3.28 (s, 3H, -OCH3); 3.16 (dd, J2-1 ¼ 3.7 Hz, J2-3 ¼ 9.9 Hz, 1H,
H2). 13C NMR (150 MHz, D2O):
d
¼ 176.63 (-C(O)OH); 96.03 (C1);
71.72 (C6); 69.82 (C3); 69.35 (C4); 59.84 (t, JC-D ¼ 22.0 Hz, C6); 55.13
(-OCH3); 53.87 (C2); 20.35 (CH3C(O)OH). ESI-HRMS: m/z calcd for
C7H15DNO5 [MþH]þ 195.1091, found 195.1098.
(s, 3H, -OCH3); 3.42 (dd, J2-1 ¼ 3.5 Hz, J2-3 ¼ 10.3 Hz, 1H, H2). 13
C
NMR (150 MHz, CDCl3):
d
¼
135.05, 135.01 (2C, arom);
126.08e125.14 (10C, arom); 96.00 (C1); 77.74 (C3); 76.21 (C4);
0
72.97(CH2); 72.60 (CH2 ); 67.82 (C5); 61.03 (C2); 52.84 (-OCH3);
4.1.11. Methyl 6-(S)-deuterio-
b
-
D
-glucosaminide monoacetate
48.19 (t, JC-D ¼ 21.9 Hz, C6). ESI-HRMS: m/z calcd for C21H23DN6O4Na
(6S-2H-5)
[M þ Na]þ 448.1819, found 448.1811.
Compound 15
b (26.1 mg, 0.065 mmol) was subjected to
hydrogenolysis and purification analogously to 15
a
to give the title
4.1.14. Methyl 2,6-diamino-2,6-dideoxy-6-(R)-deuterio-a-D-
compound 6S-2H-5 as colorless oil (6.8 mg, 0.027 mmol, 41%),
glucopyranoside diacetate (6R-2H-2)
whose non-deuteriated isotopomer was previously reported as the
The diazide 17 (25.0 mg, 0.059 mmol) was subjected to hydro-
genolysis and purification as described for 15 to give the title
compound, whose non-deuteriated isotopomer was previously
reported as the HCl salt [31,32], as its diacetate salt in the form of a
free base [30]. ½a D23
ꢀ
¼ ꢁ32.1 (c ¼ 0.1, water). 1H NMR (600 MHz,
a
D2O):
d
¼ 4.49 (d, J1-2 ¼ 8.6 Hz, 1H, H1); 3.57 (d, J6-5 ¼ 5.5 Hz, 1H,
H5); 3.51 (dd, J3-2 ¼ 10.6 Hz, J3-4 ¼ 9.2 Hz, 1H, H3); 3.42 (s, 3H,
-OCH3); 3.34 (dd, J5-4 ¼ 9.4 Hz, J5-6 ¼ 5.5 Hz, 1H, H5); 3.30 (t, J4-
colorless oil (12.3 mg, 0.039 mmol, 67%). ½a D23
¼ þ51.3 (c ¼ 0.5,
ꢀ
¼ J4-5 ¼ 9.4 Hz, 1H, H4); 2.86 (dd, J2-1 ¼ 8.6, J2-3 ¼ 10.6 Hz, 1H, H2);
water). 1H NMR (600 MHz, D2O):
d
¼ 5.01 (d, J1-2 ¼ 3.0 Hz, 1H, H1);
3
1.91 (s, 3H, CH3C(O)-). 13C NMR (150 MHz, D2O):
d
¼ 176.90 (-C(O)
3.84 (d, J5-4 ¼ 9.5 Hz, 1H, H5); 3.81 (t, J3-2 ¼ J3-4 ¼ 10.0 Hz, 1H, H3);
3.41 (s, 1H, H6); 3.41 (s, 3H, -OCH3); 3.36 (t, J4-3 ¼ J4-5 ¼ 9.8 Hz, 1H,
H4); 3.32 (dd, J2-1 ¼ 3.0 Hz, J2-3 ¼ 10.1 Hz, 1H, H2); 1.91 (s, 6H,
OH); 99.75 (C1); 76.02 (C5); 71.90 (C3); 69.66 (C4); 59.99 (t, JC-
¼ 24.0 Hz, C6); 57.34 (-OCH3); 55.64 (C2); 20.52 (CH3C(O)OH).
D
ESI-HRMS: m/z calcd for C7H15DNO5 [MþH]þ 195.1091, found
CH3COOH). 13C NMR (150 MHz, D2O):
d
¼ 179.91 (-C¼O-); 96.16
195.1083.
(C1); 71.06 (C4); 69.36 (C3); 67.67 (C5); 55.49 (-OCH3); 53.59 (C2);